Representatives Lou Correa (D-CA) and Clay Higgins (R-LA) and Senators Jon Tester (D-MT) and Dan Sullivan (R-AK) have introduced legislation, HR 712 / S. 179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans.
The legislation “would direct VA to conduct clinical research with varying forms of medicinal cannabis to evaluate the safety and effects of cannabis on health outcomes of veterans with PTSD and veterans with chronic pain.”
This legislation is similar, yet stronger, to a bill by the same name that successfully passed the House Veterans Affairs Committee last year yet was denied consideration by the full House of Representatives by Republican congressional leadership.
Upon introduction, Rep. Lou Correa said, “Last year my bill became the first cannabis bill to pass the House Veterans’ Affairs Committee. This year I will work to make this the first veterans cannabis bill to pass the House. The momentum, support, and dedication are there. We need to get this done for our veterans. With the opioid crisis raging across America, it is imperative to the health and safety of our veterans that we find alternative treatments for chronic pain and service-related injuries.”
According to nationwide survey data conducted by The American Legion in 2017, 39 percent of respondents affirmed that they “know a veteran” who is using the plant medicinally. Furthermore, twenty-two percent of respondents said they themselves “use cannabis to treat a mental or physical condition.”